Found 5 matching trials
Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases PHASE2 A single-center, single-arm, phase 2 trial of Serplulimab in combination wi...
Show More Location
the Second Affiliated Hospital of Medical College of Zhejiang University
Learn More & Join Trial
HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma PHASE2 Overall, although there are many options for second-line treatment of liver...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
TILA-TACE in Treatment of Hepatocellular Carcinoma NA To validate the tumor response rate: in the previous study, the investigato...
Show More Location
The Second affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular Carcinoma PHASE2 In recent years, with the emergence of various new targeted and immunothera...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases PHASE2 This Phase II clinical study evaluates the safety and efficacy of a combina...
Show More Location
Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial